For too long, a lack of topical innovation has left patients with chronic inflammatory diseases of the skin waiting for better treatments.
We believe patients deserve better
Arcutis supports innovation that strives to simplify complex disease management and solve the most persistent challenges of treating chronic inflammatory diseases of the skin.
With a deep understanding of what really matters to patients and healthcare professionals, we work to address their urgent, unmet needs through meaningful innovation.
At Arcutis, meaningful innovation means focusing on unmet needs in the treatment of immune-mediated skin diseases. With extensive medical dermatology development expertise and a unique dermatology drug development platform, we’re committed to meaningful advances—innovation that solves the most persistent challenges of patients, their families, and the healthcare professionals who care for them.
Founded in 2016 by a global leadership team with extensive dermatology and commercialization experience—including 50+ FDA-approved products —Arcutis has 8 dermatology clinicians as well as medical dermatology’s foremost topical drug formulator on staff. Learn more about our people, our passion, and our purpose.
The complexities of treating chronic inflammatory diseases of the skin. The need for more innovative treatments. The real, everyday needs of those living with immune-mediated skin conditions.
We want to know what matters most to you. Let us know what’s on your mind using the form below.
If you would like to report an adverse event or product complaint, please call Arcutis at 844‑692‑6729.
The information on the website you are about to enter may not comply with Canadian regulatory requirements. Marketing authorizations and availability of products may differ between Canada and other countries. You are solely responsible for your interactions with that website.
Before you download the Arcutis corporate fact sheet, please note that marketing authorizations and availability of products may differ between Canada and other countries.
Please note that the information in the environment, social, and governance (ESG) report you are about to download is US based. Marketing authorizations and availability of products may differ between Canada and other countries.